Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a randomized controlled trial
about
The host immune dynamics of pneumococcal colonization: implications for novel vaccine developmentAssessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, KenyaA longitudinal study of natural antibody development to pneumococcal surface protein A families 1 and 2 in Papua New Guinean Highland children: a cohort studyEfficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trialPneumococcal vaccination: what have we learnt so far and what can we expect in the future?Effects of Vaccination with 10-Valent Pneumococcal Non-Typeable Haemophilus influenza Protein D Conjugate Vaccine (PHiD-CV) on the Nasopharyngeal Microbiome of Kenyan Toddlers.Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries: A Systematic Review10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) induces memory B cell responses in healthy Kenyan toddlers.Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate?Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study.The Clinical Effectiveness of Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Haemophilus haemolyticus Interaction with Host Cells Is Different to Nontypeable Haemophilus influenzae and Prevents NTHi Association with Epithelial CellsIssues in pediatric vaccine-preventable diseases in low- to middle-income countries10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children.Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage.Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data.Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies.Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage.Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation
P2860
Q28084920-0A9502C0-EFD5-4167-A5FB-3F9D383D9901Q33776584-19BFDA6B-4975-42BD-AF82-4F96050D08AEQ33802029-A5BB334F-A61E-4C29-B982-01A155FEC62DQ33848675-23B570E4-6BD5-42B0-A43B-40EB5993ED77Q34798448-327C8FD2-AAD8-45AE-BE0D-B7553A727D80Q35666118-5B1F1498-646C-48FC-8656-846E305B7170Q35762530-56F7A058-8F8B-4B5A-82BF-671D705D6674Q35893171-E1A78349-7B07-4272-B347-F2B01587145CQ36187591-24439434-A3DA-4711-A4D9-ED84F8F149D0Q36256464-BFF326C9-E224-4894-865D-108ABADB831EQ36713715-898D9A35-240D-4BE6-A34B-9A9F0EA2D7CFQ36881633-90080089-44F2-471B-8011-7C078FB829DCQ37264972-5F88F197-91B0-4749-8461-75E7E170EA35Q38246355-9E0E824D-23DE-4563-A327-A62D5D9B7B81Q38652537-ABF7AA93-7E74-4FD4-9020-CB7158F5866FQ38669404-DFB9D5BB-1A0D-4636-835C-C61A3CC3FB2BQ39043548-840BFAA5-CDE4-479F-A1D7-341164390523Q39344425-DCFD5BDC-C8CF-45A3-B6A8-D33C7FDDBE2AQ58476625-D8AABE36-C0B3-4C83-8580-31E578171EC8
P2860
Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a randomized controlled trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunogenicity, impact on carr ...... a randomized controlled trial
@en
Immunogenicity, impact on carr ...... a randomized controlled trial.
@nl
type
label
Immunogenicity, impact on carr ...... a randomized controlled trial
@en
Immunogenicity, impact on carr ...... a randomized controlled trial.
@nl
prefLabel
Immunogenicity, impact on carr ...... a randomized controlled trial
@en
Immunogenicity, impact on carr ...... a randomized controlled trial.
@nl
P2093
P2860
P1433
P1476
Immunogenicity, impact on carr ...... a randomized controlled trial
@en
P2093
Ahsan Habib
Angela Karani
Dorota Borys
J Anthony G Scott
Laura L Hammitt
Mahfudh Bashraheil
Susan C Morpeth
P2860
P304
P356
10.1371/JOURNAL.PONE.0085459
P407
P577
2014-01-21T00:00:00Z